HESH(301103)

Search documents
何氏眼科与蔡司中国医疗达成多项战略合作
Zheng Quan Ri Bao Wang· 2025-09-08 07:45
Core Insights - The strategic partnership between He Eye Hospital Group and Zeiss China Medical aims to enhance the quality and precision of ophthalmic surgeries, particularly in cataract and refractive procedures [1][2] Group 1: Strategic Collaboration - He Eye Hospital and Zeiss China Medical have established six specialized technical cooperation units focusing on complex ophthalmic issues such as cataracts, high myopia correction, presbyopia correction, and astigmatism correction [1] - The collaboration signifies a new phase of deep technological integration, leveraging Zeiss's advanced optical technology and He Eye Hospital's extensive clinical resources [1][2] Group 2: Goals and Vision - The partnership aims to create a comprehensive innovation system from technology research and development to clinical application, promoting standardized and precise refractive cataract and presbyopia surgeries [1] - Both companies emphasize a patient-centered approach and the use of digital and intelligent methods to enhance access to quality ophthalmic resources across regions, contributing to the "Healthy China" strategy [2]
何氏眼科“视界之光”百千万眼科及视光人才培训计划升级启动
Zheng Quan Ri Bao Zhi Sheng· 2025-09-07 10:12
Group 1 - The core viewpoint of the article is the launch of the upgraded "Vision Light" training program by Liaoning He Eye Hospital Group, which aims to respond to the national eye health strategy by training a significant number of eye care professionals [1] - The training program is supported by the National Health Commission's blindness prevention training base and Liaoning He Medical College, focusing on systematic, large-scale, and precise training [1] - The program aims to cultivate 100 leaders in ophthalmology and optometry, 1,000 technical backbone talents, and 10,000 grassroots professionals over the coming years, establishing a talent pipeline for the entire eye health industry [1] Group 2 - The initiative is expected to enhance the quality and accessibility of eye care services in China by gathering expert knowledge and industry resources [1]
何氏眼科:打造“365近视防控模式” 推动近视防控数字化转型
Zhong Zheng Wang· 2025-09-07 05:49
Core Insights - The "365 Myopia Prevention and Control Model" aims to transform myopia prevention from a single treatment approach to a digital model encompassing "prevention-intervention-management" for children and adolescents [1][2] - The model features three interconnected scenarios, six core technologies, and five management systems, emphasizing personalized and precise strategies for myopia control [1][2] Group 1 - The three interconnected scenarios include schools, families, and professional institutions, creating a comprehensive myopia prevention system that covers children's daily life and learning environments [2] - The six core technologies focus on genetics, environment, medicine and optics, eye load, behavior, and nutrition, providing robust technical support for effective myopia prevention and management [2] - The five management systems integrate various aspects such as myopia early warning assessment, personalized control plans, high myopia management, treatment of myopia-related eye diseases, and intelligent eye health management [2] Group 2 - The release of the white paper represents a significant achievement in the "He’s Smart Bright City" strategy within the myopia prevention field, showcasing a new digital, comprehensive, and lifecycle-oriented eye health management service model [2] - This initiative marks a critical step towards the intelligent, precise, and inclusive transformation of traditional myopia prevention methods [2]
何氏眼科分别与强生眼力健、蔡司医疗达成战略合作并升级启动“视界之光”百千万眼科及视光人才培训计划
Zheng Quan Shi Bao Wang· 2025-09-07 04:11
Core Insights - He Eye Hospital has formed significant strategic partnerships with Johnson & Johnson Vision and Zeiss Medical during the 29th Chinese Ophthalmology Academic Conference (CCOS2025) [1] - The company has launched an upgraded "Vision Light" training program aimed at cultivating a new generation of ophthalmology and optometry professionals [4] Group 1: Strategic Partnerships - The collaboration with Johnson & Johnson Vision focuses on two strategic innovation groups, including a "Global Innovation Technology Strategic Cooperation Group" for cataract surgery, which will utilize the seventh-generation "Catalys" femtosecond laser system [2] - The partnership aims to explore high-quality visual solutions, including the use of advanced artificial lenses designed for Asian patients, addressing cataracts, presbyopia, and astigmatism [2] - The partnership with Zeiss Medical involves the establishment of six specialized technical cooperation units to tackle common and complex ophthalmic issues, leveraging Zeiss's optical technology and He Eye Hospital's clinical resources [3] Group 2: Training Program - The "Vision Light" training program aims to train 100 leading ophthalmology and optometry professionals, 1,000 technical backbones, and 10,000 grassroots professionals over the coming years [4] - The program will utilize resources from the National Health Commission's blindness prevention training base and the professional advantages of Liaoning He Medical College [4] - He Eye Hospital's training academy will implement an innovative training model that combines theory and practice to enhance the professional skills and clinical thinking of participants [4]
何氏眼科分别与强生眼力健、蔡司医疗达成战略合作并升级启动"视界之光"百千万眼科及视光人才培训计划
Zheng Quan Shi Bao Wang· 2025-09-07 03:55
Group 1 - He Eye Hospital has formed significant strategic partnerships with Johnson & Johnson Vision and Zeiss Medical during the CCOS2025 conference [1] - The collaboration with Johnson & Johnson Vision focuses on two strategic groups aimed at driving innovation in refractive cataract surgery and presbyopia treatment [2] - The partnership with Zeiss Medical includes the establishment of six specialized technical cooperation units to address common ophthalmic issues such as cataracts and high myopia [3] Group 2 - He Eye Hospital has launched the "Vision of Light" training program to cultivate a new generation of ophthalmic and optometry professionals, aiming to train 100 leaders, 1,000 technical experts, and 10,000 grassroots professionals [4] - The training program will leverage resources from the National Health Commission and Liaoning He Medical College to create a comprehensive talent pipeline for the eye health industry [4] - The program emphasizes a seamless integration of theory and practice to enhance professional skills and clinical thinking among trainees [4]
“何氏智慧光明城”创新实践成果亮相CCOS2025
Zheng Quan Ri Bao Zhi Sheng· 2025-09-06 04:39
Core Viewpoint - The release of the "365 Myopia Prevention and Control Model (2025 Edition)" white paper aims to transform myopia prevention from a single treatment approach to a comprehensive digital strategy encompassing prevention, intervention, and management for children and adolescents [1] Group 1: Company Initiatives - The white paper was collaboratively developed by Liaoning He Eye Hospital Group Co., Ltd., Liaoning He Medical College, and experts from the He Eye Industry Group [1] - The "He Smart Light City" strategy represents a significant practical outcome in the field of myopia prevention, focusing on a full lifecycle eye health smart industry ecosystem [1] Group 2: Technological Integration - The ecosystem integrates various business sectors including medical, education, production, and research, leveraging advanced technologies such as big data, artificial intelligence, genetics, and stem cells [1] - The initiative aims to innovate continuously in precision medicine and smart healthcare, promoting intelligent, precise, and inclusive eye health and overall health solutions [1]
何氏眼科发布《365近视防控模式(2025版)》白皮书
Zheng Quan Shi Bao Wang· 2025-09-06 02:15
Core Viewpoint - The release of the "365 Myopia Prevention and Control Model (2025 Edition)" white paper aims to transform myopia prevention from a single treatment approach to a comprehensive digital strategy encompassing prevention, intervention, and management for children and adolescents [1][2] Group 1: Myopia Prevention and Control Strategy - The white paper is a significant outcome of the "He’s Smart Light City" strategy in the field of myopia prevention [1] - The "365 Myopia Prevention and Control Model" focuses on a human-centered approach, characterized by intelligence, precision, efficiency, and personalization [1] - The model includes a comprehensive management system that transitions from a "one-size-fits-all" approach to "tailored solutions" for individuals [1] Group 2: Key Components of the Model - The model establishes a three-dimensional prevention system involving schools, families, and professional institutions to cover all aspects of children's lives and learning environments [2] - It incorporates six core technologies addressing genetics, environment, medicine, optics, eye strain, behavior, and nutrition to support myopia prevention and control from multiple dimensions [2] - The model integrates five management systems, including a myopia early warning assessment system, personalized control plans, high myopia management, treatment for myopia-related eye diseases, and an intelligent eye health management system [2]
屈光手术业务增长放缓,眼科医疗企业欲借新技术谋突围
Di Yi Cai Jing· 2025-09-02 08:18
Core Viewpoint - The ophthalmology medical industry is experiencing a slowdown in the growth of refractive surgery revenue, with many companies reporting single-digit growth rates in this segment, while a few are still achieving double-digit growth. Group 1: Industry Overview - The refractive surgery business, a significant revenue source for private ophthalmology institutions, has shown a general trend of slowing growth in recent years [1] - Among five listed ophthalmology companies in A-shares, three reported refractive project revenue growth at single-digit levels or below in the first half of the year [1] - Specific growth figures include: - Puyi Eye Hospital (301239.SZ) with a 4.13% increase to 720 million yuan, accounting for 49% of total revenue [1] - He’s Eye Hospital (301103.SZ) with a 3.26% increase to 135 million yuan, accounting for 24% of total revenue [1] - Guangzheng Eye Hospital (002524.SZ) with a 0.32% increase to 142 million yuan, accounting for 32.71% of total revenue [1] - Aier Eye Hospital (300015.SZ) and Huaxia Eye Hospital (301267.SZ) are exceptions, achieving revenue growth rates of 11.4% and 13.75%, respectively [1] Group 2: Company Strategies - Aier Eye Hospital attributes its revenue growth in refractive projects to the acceptance of new surgical techniques such as All-Laser LASIK and the expansion of its medical network, enhancing patient coverage [3] - Puyi Eye Hospital is focusing on introducing authoritative expert teams and updating high-end diagnostic equipment to cultivate new growth points in the competitive refractive and vision care market [3] Group 3: Market Demand and Trends - The current refractive surgery patient population is divided into two categories: those with essential needs due to academic or professional requirements and those seeking aesthetic improvements [4] - Despite a stable demand from the essential needs group, the decision-making cycle for non-essential consumers is lengthening due to macroeconomic factors [4] - There is significant unmet demand in the refractive surgery market, with approximately 700 million myopic patients in China, but only about 1 million undergoing surgery annually [4] - The Z generation shows a personalized and urgent demand for vision correction, driving innovation and iteration in refractive surgery technologies [4] - Aierkon has introduced new refractive surgery solutions, such as All-Laser LASIK, which allows for personalized treatment based on various eye data [4] Group 4: Technology Adoption - Aierkon's All-Laser LASIK equipment has seen over 50,000 surgeries performed since its launch at the 2023 China International Import Expo, with over 100 hospitals equipped nationwide [5] - The company emphasizes the need for continued market education to enhance the penetration of new technologies [5]
屈光手术业务增长放缓 眼科医疗企业欲借新技术谋突围
Di Yi Cai Jing· 2025-09-02 08:18
Core Viewpoint - The refractive surgery business of private ophthalmology medical institutions is experiencing a slowdown in revenue growth, with several companies reporting single-digit growth rates in their refractive project revenues [1][2]. Group 1: Revenue Growth Analysis - Among five listed ophthalmology medical companies, three reported refractive project revenue growth at single-digit levels or below in the first half of the year. Specifically, Purui Eye Hospital (301239.SZ) saw a 4.13% increase to 720 million yuan, accounting for 49% of its total revenue; He’s Eye Hospital (301103.SZ) reported a 3.26% increase to 135 million yuan, making up 24% of its revenue; and Guangzheng Eye Hospital (002524.SZ) had a 0.32% increase to 142 million yuan, representing 32.71% of its revenue [1]. - In contrast, Aier Eye Hospital (300015.SZ) and Huaxia Eye Hospital (301267.SZ) managed to maintain double-digit growth rates in their refractive project revenues, with increases of 11.4% and 13.75%, respectively [1]. Group 2: Competitive Strategies - To navigate the competitive refractive surgery market, companies are leveraging new technologies. Aier Eye Hospital reported that its revenue growth in refractive projects is driven by the acceptance of new surgical techniques such as all-laser and full-femtosecond procedures, which have improved the business structure and increased average prices [2]. - Purui Eye Hospital is also responding to market competition by continuously introducing authoritative expert teams and updating high-end diagnostic equipment to cultivate new growth points [2]. Group 3: Market Demand and Trends - The current refractive surgery patient population can be divided into two groups: one with essential needs due to academic or professional requirements, and another seeking aesthetic improvements by eliminating glasses or contact lenses [2]. - Despite the large number of myopic patients in China, estimated at around 700 million, only about 1 million undergo refractive surgery annually, indicating significant unmet demand and potential for market penetration [3]. - The Z generation shows a personalized and urgent demand for vision correction, pushing for technological innovation and customization in refractive surgery [3].
眼科医疗行业业绩分化加剧,技术创新成突围关键
2 1 Shi Ji Jing Ji Bao Dao· 2025-09-02 07:41
Core Insights - The ophthalmology sector is experiencing significant performance differentiation among listed companies, with Aier Eye Hospital leading in revenue and net profit growth, while others like He Eye Hospital and Guangzheng Eye Hospital face revenue declines [1][4][6]. Revenue Performance - Aier Eye Hospital reported a revenue of 11.507 billion, a year-on-year increase of 9.12%, maintaining its leading position in the market [2][4]. - Huaxia Eye Hospital and Purui Eye Hospital followed with revenues exceeding 1.4 billion, while He Eye Hospital and Guangzheng Eye Hospital reported revenues around 500 million, both experiencing year-on-year declines of 4.22% and 9.49% respectively [2][4]. Net Profit Analysis - Aier Eye Hospital's net profit reached 2.051 billion, with a growth rate of 0.05% [2][4]. - He Eye Hospital achieved a remarkable net profit growth of 84.19%, totaling 44 million, making it the fastest-growing listed ophthalmology company in terms of net profit [2][4]. - Purui Eye Hospital's net profit significantly dropped by 66.12%, amounting to 15 million, indicating substantial challenges in profitability [2][4]. Market Dynamics - The ophthalmology market in China is projected to reach 223.1 billion by 2024, with a year-on-year growth of 11.05%, and private institutions holding a 42% market share [4][6]. - Refractive and cataract surgeries account for 47% of the overall market, with refractive surgery alone valued at 73 billion [4][6]. Competitive Landscape - The industry is shifting from "scale expansion" to "quality enhancement," with technological innovation and policy adaptability becoming key competitive barriers [3][8]. - The increasing number of ophthalmology service providers has intensified competition, leading to a "red ocean" scenario where weaker players may exit the market [6][8]. Strategic Responses - Companies like Aier Eye Hospital are focusing on acquisitions and expanding their service networks to enhance market presence and service quality [6][7]. - Huaxia Eye Hospital is improving management systems and accelerating the construction of hospitals and vision centers to strengthen its market position [7][8]. Technological Innovation - Technological advancements, particularly in refractive surgery, are crucial for companies to differentiate themselves and improve profitability [8][9]. - Aier Eye Hospital's refractive project revenue grew by 11.14%, driven by the promotion of new surgical techniques [9][10]. Consumer Trends - The demand for vision correction among the Z generation is characterized by a strong preference for personalized and high-quality services, driving rapid innovation in refractive surgery techniques [10][11]. - The market is transitioning towards a more customized approach in vision correction, with new technologies like All-Laser LASIK gaining traction [10][11].